Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Interferon beta is commonly used to treat patients with relapsing-remitting multiple sclerosis; however, the treatment is only partially effective in reducing relapses and progression of disability. Corticosteroids are used to treat relapses in patients with multiple sclerosis. We therefore aimed to investigate the combination of cyclic methylprednisolone and interferon beta for the treatment of relapsing-remitting multiple sclerosis.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Lancet Neurology |
Vol/bind | 9 |
Udgave nummer | 7 |
Sider (fra-til) | 672-80 |
Antal sider | 9 |
ISSN | 1474-4422 |
DOI | |
Status | Udgivet - 1 jul. 2010 |
ID: 34093085